Movatterモバイル変換


[0]ホーム

URL:


CN105669804A - Preparation method of sofosbuvir - Google Patents

Preparation method of sofosbuvir
Download PDF

Info

Publication number
CN105669804A
CN105669804ACN201610181055.6ACN201610181055ACN105669804ACN 105669804 ACN105669804 ACN 105669804ACN 201610181055 ACN201610181055 ACN 201610181055ACN 105669804 ACN105669804 ACN 105669804A
Authority
CN
China
Prior art keywords
preparation
suo feibuwei
solvent
reaction
pentafluorophenol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610181055.6A
Other languages
Chinese (zh)
Other versions
CN105669804B (en
Inventor
李泽标
朱明敏
张庆海
朱功凤
张兆国
林燕峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nantong Chang You Medicine Co Science And Technology Ltd
Original Assignee
Nantong Chang You Medicine Co Science And Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nantong Chang You Medicine Co Science And Technology LtdfiledCriticalNantong Chang You Medicine Co Science And Technology Ltd
Priority to CN201610181055.6ApriorityCriticalpatent/CN105669804B/en
Publication of CN105669804ApublicationCriticalpatent/CN105669804A/en
Application grantedgrantedCritical
Publication of CN105669804BpublicationCriticalpatent/CN105669804B/en
Activelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Classifications

Landscapes

Abstract

The invention discloses a preparation method of sofosbuvir. The preparation method includes following steps: in the absence of water and oxygen, enabling (2'R)-2'-deoxidized-2'-fluorine-2'-methyluridine, N-[(S)-(2, 3, 4, 5, 6-pentafluorophenoxy) phenoxy phosphoryl]-L-alanine isopropyl ester and Grignard reagent to react in the presence of a reaction solvent; dissolving mother liquid of sofosbuvir in a solvent, adding an adsorbent, depressurizing for concentration to be dry, adding solvent, pulping at room temperature, suction filtering, collecting filtrate, depressurizing for evaporation to dryness to obtain a oily product, adding solvent into the oily product, heating for dissolving to clearness, and cooling to 0-5 DEG C for crystallization to obtain recycled pentafluorophenyl; enabling D-alanine isopropyl ester and phenyl dichlorophosphate to be in reaction at minus 70-minus 80 DEG C, and adding a solvent solution of pentafluorophenyl and alkali for reaction to obtain a compound shown in a formula II. In the synthesis process of sofosbuvir, molecular pentafluorophenyl is removed, and pentafluorophenyl is recycled and used for preparation of an intermediate of sofosbuvir synthesis materials, so that pentafluorophenyl is recycled and influence on environment is reduced.

Description

The preparation method of Suo Feibuwei
Technical field
The preparation method that the present invention relates to a kind of anti-HCV medicament, the preparation method particularly relating to a kind of Suo Feibuwei.
Background technology
Suo Feibuwei, Sofosbuvir, chinesization formal name used at school is N-[ (S)-2-(S)-(2R, 3R, 4R, 5R)-5-(2,4-dioxo-3,4-dihydro-pyrimidin-1 (2H)-Ji)-4-fluoro-3-hydroxy-4-methyl oxolane-2-base) methoxyl group) (phenoxy group) phosphinylidyne amino) isopropyl propionate (structural formula is as shown in Equation 2); CAS registration number: 1193037-88-0. Suo Feibuwei is developed by beautiful Pharmasset pharmacy corporation, and exploitation listing after lucky Deco (GileadSci) corporate buyout, code name is GS-7977. FDA (Food and Drug Adminstration) (FoodandDrugAdministration, FDA) ratifies listing on 6th first in December in 2013, and preparation is tablet 400mg, trade name Sovaldi. Structure is formula 1 such as:
It is a kind of viral hepatitis being infected by hepatitis C virus (HCV) and causing that hepatitis C (is called for short hepatitis C, hepatitis C). Adding up according to World Health Organization (WHO), the infection rate of whole world hepatitis C is about 3%, about 1.8 hundred million people's HCV infection, annual new hepatitis C case about 3.5 ten thousand example. Hepatitis C is global prevalence, may result in that liver chronic inflammatory disease is downright bad and fibrosis, has 1%~5% can develop into liver cirrhosis even hepatocarcinoma (HCC) and dead in 100 patients.
Suo Feibuwei is the first anti-HCV medicament that can be used for the full oral treatment regimes of hepatitis C. Before Suo Feibuwei comes out, hepatitis C patient must accept the treatment of at least 6 months, including injectable drug interferon and ribavirin, and both medicines can cause serious similar flu-like symptom and the side effect such as erythra, anemia respectively, its cure rate is only 45% simultaneously, and the cure rate of Suo Feibuwei is more than 90%, revolutionize the low cure rate situation of hepatitis C.
Ji Leadd B.V of the U.S. of Yuan Yan enterprise reports the synthesis of Suo Feibuwei product in patent US2013029929, is prepared with the fluoro-2'-MU glycosides of (2'R)-2'-deoxidation-2'-and phosphate ester side chain for raw material and forms.Owing to Suo Feibuwei building-up process being taken off a part Pentafluorophenol, and Pentafluorophenol is be worth higher industrial chemicals, and there is certain toxicity and environment is had impact by it because of it, the former recovery grinding not mentioned Pentafluorophenol in patent and utilization, therefore the recovery of Pentafluorophenol has great importance.
Accordingly, it is desirable to provide a kind of new technical scheme solves the problems referred to above.
Summary of the invention
The preparation method that the technical problem to be solved in the present invention is to provide a kind of Suo Feibuwei, is the new drug for treating chronic hepatitis c.
For solving above-mentioned technical problem, the preparation method of the Suo Feibuwei of the present invention, comprise the following steps:
(1) preparation of Suo Feibuwei:
;
When anhydrous and oxygen-free, (2'R) the fluoro-2'-MU glycosides of-2'-deoxidation-2'-, N-[(S)-(2, 3, 4, 5, 6-phenyl-pentafluoride oxygen base) phenoxy group phosphoryl]-ALANINE isopropyl ester and grignard reagent react under reaction dissolvent existence condition, after completion of the reaction, dropping concentrated hydrochloric acid and shrend are gone out reaction, remove reaction dissolvent under reduced pressure, then extract, merge organic facies, dry again, sucking filtration, concentrating under reduced pressure, obtain grease crude product, dichloromethane is added in grease crude product, add thermosol clear, then stirring and crystallizing at being cooled to 0-10 DEG C, after sucking filtration mother liquid obtained for reclaiming Pentafluorophenol, filter cake dries to obtain white solid product Suo Feibuwei,
(2) mother solution of the recovery of Pentafluorophenol: Suo Feibuwei dissolves in a solvent, it is subsequently added adsorbent, is evaporated to dry, again add solvent, pull an oar in room temperature, sucking filtration, collects filtrate, and evaporated under reduced pressure obtains grease, solvent is added again in grease, add thermosol clear, be then cooled to 0-5 DEG C of crystallize, obtain the Pentafluorophenol of recovery;
(3) preparation of formula II compound: D-alanine isopropyl ester and dichloro-phenyl phosphate, reacts at-70~-80 DEG C, adds solvent solution and the alkali of Pentafluorophenol, and reaction prepares formula II compound.
In step (1); (2'R) the fluoro-2'-MU glycosides of-2'-deoxidation-2'-, N-[(S)-(2,3,4; 5,6-phenyl-pentafluoride oxygen bases) phenoxy group phosphoryl]-ALANINE isopropyl ester, grignard reagent charge ratio be 1:1.05:1.1~1:1.5:1.8.
In step (2), the mass ratio adding adsorbent, adsorbent and mother solution in the mother solution of Suo Feibuwei is 1:2~1:5.
In step (3), D-alanine isopropyl ester, dichloro-phenyl phosphate, Pentafluorophenol charge ratio are 1:0.9:1.05~1:1.3:1.6.
In technique scheme, the grignard reagent in step (1) is tert-butyl group magnesium chloride, isopropylmagnesium chloride; Reaction dissolvent in step (1) is oxolane, toluene, dimethylformamide or dimethyl sulfoxide.
Adsorbent in step (2) is silica gel; Solvent in step (2) is diisopropyl ether, methyl tertiary butyl ether(MTBE), normal hexane, ethyl acetate or dichloromethane.
Alkali in step (3) is triethylamine, piperidines; Solvent in step (3) is dichloromethane, toluene, methyl tertiary butyl ether(MTBE), ethyl acetate, normal hexane.
Beneficial effects of the present invention: applying grignard reagent in the Suo Feibuwei building-up process of the present invention and carry out the Butt-coupling of master chain, easy and simple to handle, impurity is easily controllable, is beneficial to large-scale production. And course of reaction is taken off a part Pentafluorophenol, and Pentafluorophenol has been reclaimed, Pentafluorophenol is for the preparation of one of Suo Feibuwei synthesis material intermediate so that Pentafluorophenol recycling, reduces the impact on environment.
Detailed description of the invention
In order to deepen the understanding of the present invention, below the invention will be further described, this embodiment is only used for explaining the present invention, is not intended that the restriction to protection scope of the present invention.
Embodiment 1
The preparation method of the Suo Feibuwei of the present invention, comprises the following steps:
The preparation of Suo Feibuwei:
In reaction bulb, when anhydrous and oxygen-free, add the fluoro-2'-MU glycosides of 120g (2'R)-2'-deoxidation-2'-, 600mL oxolane, stirring, be cooled to-30 DEG C, drip 268g1.7M tert-butyl group magnesium chloride; Drip and finish, stirring reaction 1 hour, then heat to-10 DEG C, the 500mL tetrahydrofuran solution of dropping 230gN-[(S)-(2,3,4,5,6-phenyl-pentafluoride oxygen base) phenoxy group phosphoryl]-ALANINE isopropyl ester; Dripping and finish, react 1 hour, then heat to room temperature reaction at-10 DEG C, TLC monitors reaction. React complete, be cooled to 0 DEG C, start to drip concentrated hydrochloric acid/water (100mL/600mL) cancellation reaction; Removing oxolane under reduced pressure, be subsequently adding 800mL ether, stir separatory, water layer ether (300mL × 3) extracts, and merges organic facies, and with saturated sodium bicarbonate solution, saturated sodium-chloride, anhydrous sodium sulfate dries, sucking filtration, concentrating under reduced pressure, obtains 195g grease crude product; In grease crude product, add 3 times amount dichloromethane, add thermosol clear, stirring and crystallizing at being then cooled to 0-10 DEG C, sucking filtration, dry to obtain 176g white solid product.
The recovery of Pentafluorophenol:
By the mother liquor concentrations liquid of 220g Suo Feibuwei, add in 800mL diisopropyl ether and dissolve, add silica gel 440g, after stirring, it is evaporated to dry, adds 800mL diisopropyl ether, pull an oar in room temperature (20-25 DEG C), sucking filtration, filter cake diisopropyl ether rinses, and collects filtrate; Filter cake is pulled an oar at 800m diisopropyl ether again, sucking filtration, collects filtrate; Repeat aforesaid operations once, merging filtrate, evaporated under reduced pressure obtains 95g grease; In this grease, add 100mL dichloromethane and 200mL methyl tertiary butyl ether(MTBE), stirring, add thermosol clear, be then cooled to 0-5 DEG C of crystallize, sucking filtration, dry to obtain 45g yellow solid.
The preparation of formula II compound:
In reaction bulb, add 30gD-alanine isopropyl ester grease, 200ml dichloromethane and 20g anhydrous sodium sulfate, stirring, be cooled to-70~-80 DEG C, the 500ml dichloromethane solution of dropping 48g dichloro-phenyl phosphate; Drip and finish, insulation reaction 1 hour at-70~-80 DEG C, then drip dichloromethane solution and the 45g triethylamine of the Pentafluorophenol (42g) of above-mentioned recovery successively; Drip and finish, warm naturally to 0-5 DEG C, stirring, filter, filter cake 200ml dichloromethane, filtrate reduced in volume is concentrated into dry, obtains grease; Adding the making beating of 800mL methyl tertiary butyl ether(MTBE) in this grease, filter, filtrate reduced in volume, to dry, obtains 85g crude product; In this crude product, add 200ml ethyl acetate and 300ml normal hexane, stirring, be warming up to 50 DEG C, be then cooled to room temperature crystallize, sucking filtration, dry to obtain 72g white solid product.
Embodiment 2
The preparation method of the Suo Feibuwei of the present invention, comprises the following steps:
The preparation of Suo Feibuwei:
In reaction bulb, when anhydrous and oxygen-free, add the fluoro-2'-MU glycosides of 95g (2'R)-2'-deoxidation-2'-, 500mL oxolane, stirring, be cooled to-30 DEG C, drip 213g2.0M isopropylmagnesium chloride; Drip and finish, stirring reaction 1 hour, then heat to-10 DEG C, the 400mL tetrahydrofuran solution of dropping 198gN-[(S)-(2,3,4,5,6-phenyl-pentafluoride oxygen base) phenoxy group phosphoryl]-ALANINE isopropyl ester; Dripping and finish, react 1 hour, then heat to room temperature reaction at-10 DEG C, TLC monitors reaction.React complete, be cooled to 0 DEG C, start to drip concentrated hydrochloric acid/water (200mL/500mL) cancellation reaction; Removing oxolane under reduced pressure, be subsequently adding 600mL ether, stir separatory, water layer ether (200mL × 3) extracts, and merges organic facies, and with saturated sodium bicarbonate solution, saturated sodium-chloride, anhydrous sodium sulfate dries, sucking filtration, concentrating under reduced pressure, obtains 152g grease crude product; In grease crude product, add 3 times amount dichloromethane, add thermosol clear, stirring and crystallizing at being then cooled to 0-10 DEG C, sucking filtration, dry to obtain 136g white solid product.
The recovery of Pentafluorophenol:
By the mother liquor concentrations liquid of 160g Suo Feibuwei, add in 600mL methyl tertiary butyl ether(MTBE) and dissolve, add silica gel 480g, after stirring, it is evaporated to dry, adds 600mL methyl tertiary butyl ether(MTBE), pull an oar in room temperature (20-25 DEG C), sucking filtration, filter cake methyl tertiary butyl ether(MTBE) rinses, and collects filtrate; Filter cake is pulled an oar at 600m methyl tertiary butyl ether(MTBE) again, sucking filtration, collects filtrate; Repeat aforesaid operations once, merging filtrate, evaporated under reduced pressure obtains 70g grease; In this grease, add 80mL dichloromethane and 150mL methyl tertiary butyl ether(MTBE), stirring, add thermosol clear, be then cooled to 0-5 DEG C of crystallize, sucking filtration, dry to obtain 35g yellow solid.
The preparation of formula II compound:
In reaction bulb, add 23gD-alanine isopropyl ester grease, 150ml toluene and 10g anhydrous sodium sulfate, stirring, be cooled to-70~-80 DEG C, the 300ml toluene solution of dropping 42g dichloro-phenyl phosphate; Drip and finish, insulation reaction 1 hour at-70~-80 DEG C, then drip toluene solution and the 40g piperidines of the Pentafluorophenol (34g) of above-mentioned recovery successively; Drip and finish, warm naturally to 0-5 DEG C, stirring, filter, filter cake 150ml toluene rinses, and filtrate reduced in volume is concentrated into dry, obtains grease; Adding the making beating of 500mL methyl tertiary butyl ether(MTBE) in this grease, filter, filtrate reduced in volume, to dry, obtains 58g crude product; In this crude product, add 100ml ethyl acetate and 250ml normal hexane, stirring, be warming up to 50 DEG C, be then cooled to room temperature crystallize, sucking filtration, dry to obtain 53g white solid product.
Embodiment 3
The preparation method of the Suo Feibuwei of the present invention, comprises the following steps:
The preparation of Suo Feibuwei:
In reaction bulb, when anhydrous and oxygen-free, add the fluoro-2'-MU glycosides of 140g (2'R)-2'-deoxidation-2'-, 600mL dimethyl sulfoxide, stirring, be cooled to-30 DEG C, drip 339g2.0M isopropylmagnesium chloride; Drip and finish, stirring reaction 1 hour, then heat to-10 DEG C, the 500mL dimethyl sulphoxide solution of dropping 50gN-[(S)-(2,3,4,5,6-phenyl-pentafluoride oxygen base) phenoxy group phosphoryl]-ALANINE isopropyl ester; Dripping and finish, react 1 hour, then heat to room temperature reaction at-10 DEG C, TLC monitors reaction. React complete, be cooled to 0 DEG C, start to drip concentrated hydrochloric acid/water (250mL/700mL) cancellation reaction; Removing dimethyl sulfoxide under reduced pressure, be subsequently adding 800mL ether, stir separatory, water layer ether (300mL × 3) extracts, merging organic facies, with saturated sodium bicarbonate solution, saturated sodium-chloride, anhydrous sodium sulfate dries, sucking filtration, concentrating under reduced pressure, obtain 224g grease crude product; In grease crude product, add 3 times amount dichloromethane, add thermosol clear, stirring and crystallizing at being then cooled to 0-10 DEG C, sucking filtration, dry to obtain 202g white solid product.
The recovery of Pentafluorophenol:
By the mother liquor concentrations liquid of 240g Suo Feibuwei, add in 800mL normal hexane and dissolve, add silica gel 960g, after stirring, it is evaporated to dry, adds 800mL normal hexane, pull an oar in room temperature (20-25 DEG C), sucking filtration, filter cake normal hexane rinses, and collects filtrate;Filter cake is pulled an oar in 800m normal hexane again, sucking filtration, collects filtrate; Repeat aforesaid operations once, merging filtrate, evaporated under reduced pressure obtains 125g grease; In this grease, add 130mL dichloromethane and 250mL methyl tertiary butyl ether(MTBE), stirring, add thermosol clear, be then cooled to 0-5 DEG C of crystallize, sucking filtration, dry to obtain 64g yellow solid.
The preparation of formula II compound:
In reaction bulb, add 34gD-alanine isopropyl ester grease, 300ml methyl tertiary butyl ether(MTBE) and 20g anhydrous sodium sulfate, stirring, be cooled to-70~-80 DEG C, the 500ml t-butyl methyl ether solution of dropping 72g dichloro-phenyl phosphate; Drip and finish, insulation reaction 1 hour at-70~-80 DEG C, then drip t-butyl methyl ether solution and the 55g piperidines of the Pentafluorophenol (63g) of above-mentioned recovery successively; Drip and finish, warm naturally to 0-5 DEG C, stirring, filter, filter cake 300ml methyl tertiary butyl ether(MTBE) rinses, and filtrate reduced in volume is concentrated into dry, obtains grease; Adding the making beating of 800mL methyl tertiary butyl ether(MTBE) in this grease, filter, filtrate reduced in volume, to dry, obtains 98g crude product; In this crude product, add 200ml ethyl acetate and 400ml normal hexane, stirring, be warming up to 50 DEG C, be then cooled to room temperature crystallize, sucking filtration, dry to obtain 75g white solid product.

Claims (7)

When anhydrous and oxygen-free, (2'R) the fluoro-2'-MU glycosides of-2'-deoxidation-2'-, N-[(S)-(2, 3, 4, 5, 6-phenyl-pentafluoride oxygen base) phenoxy group phosphoryl]-ALANINE isopropyl ester and grignard reagent react under reaction dissolvent existence condition, after completion of the reaction, dropping concentrated hydrochloric acid and shrend are gone out reaction, remove reaction dissolvent under reduced pressure, then extract, merge organic facies, dry again, sucking filtration, concentrating under reduced pressure, obtain grease crude product, dichloromethane is added in grease crude product, add thermosol clear, then stirring and crystallizing at being cooled to 0-10 DEG C, after sucking filtration mother liquid obtained for reclaiming Pentafluorophenol, filter cake dries to obtain white solid product Suo Feibuwei,
CN201610181055.6A2016-03-282016-03-28The preparation method of Suo FeibuweiActiveCN105669804B (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN201610181055.6ACN105669804B (en)2016-03-282016-03-28The preparation method of Suo Feibuwei

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201610181055.6ACN105669804B (en)2016-03-282016-03-28The preparation method of Suo Feibuwei

Publications (2)

Publication NumberPublication Date
CN105669804Atrue CN105669804A (en)2016-06-15
CN105669804B CN105669804B (en)2018-08-17

Family

ID=56224100

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201610181055.6AActiveCN105669804B (en)2016-03-282016-03-28The preparation method of Suo Feibuwei

Country Status (1)

CountryLink
CN (1)CN105669804B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN106905398A (en)*2017-01-252017-06-30浙江农林大学A kind of synthetic method of Suo Feibuwei
CN107253971A (en)*2017-07-182017-10-17江苏正济药业股份有限公司A kind of Suo Feibuwei preparation method
CN109422790A (en)*2017-08-282019-03-05常州制药厂有限公司A kind of new preparation process of Suo Feibuwei
CN109467577A (en)*2018-12-062019-03-15南通常佑药业科技有限公司A kind of preparation method of Suo Feibuwei crystal form and amorphous products
CN113234102A (en)*2021-05-182021-08-10宁波大学Three-coordinate phosphorus derivative and intermediate and preparation method thereof
CN115925754A (en)*2022-10-242023-04-07江苏阿尔法药业股份有限公司Catalytic synthesis process of sofosbuvir

Citations (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN1847210A (en)*2005-04-112006-10-18临海市永太化工有限公司 A kind of method of producing pentafluorophenol
WO2010135569A1 (en)*2009-05-202010-11-25Pharmasset, Inc.N- [ (2 ' r) -2 ' -deoxy-2 ' -fluoro-2 ' -methyl-p-phenyl-5 ' -uridylyl] -l-alanine 1-methylethyl ester and process for its production
CN104151352A (en)*2014-07-232014-11-19上海彩迩文生化科技有限公司Preparation method of sofosbuvir intermediate
CN104693010A (en)*2015-02-152015-06-10浙江永太科技股份有限公司Method for synthesizing 2,3,4,5,6-pentafluorophenol
CN104761582A (en)*2014-01-082015-07-08上海创诺医药集团有限公司Method for preparation of N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxy phosphoryl]-L-alanine isopropyl ester
CN104829668A (en)*2015-05-192015-08-12江苏福瑞生物医药有限公司New method for recovering nucleoside phosphoramidate medicine mother liquor

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN1847210A (en)*2005-04-112006-10-18临海市永太化工有限公司 A kind of method of producing pentafluorophenol
WO2010135569A1 (en)*2009-05-202010-11-25Pharmasset, Inc.N- [ (2 ' r) -2 ' -deoxy-2 ' -fluoro-2 ' -methyl-p-phenyl-5 ' -uridylyl] -l-alanine 1-methylethyl ester and process for its production
CN104761582A (en)*2014-01-082015-07-08上海创诺医药集团有限公司Method for preparation of N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxy phosphoryl]-L-alanine isopropyl ester
CN104151352A (en)*2014-07-232014-11-19上海彩迩文生化科技有限公司Preparation method of sofosbuvir intermediate
CN104693010A (en)*2015-02-152015-06-10浙江永太科技股份有限公司Method for synthesizing 2,3,4,5,6-pentafluorophenol
CN104829668A (en)*2015-05-192015-08-12江苏福瑞生物医药有限公司New method for recovering nucleoside phosphoramidate medicine mother liquor

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BRUCE S. ROSS,等: "Synthesis of Diastereomerically Pure Nucleotide Phosphoramidates", 《THE JOURNAL OF ORGANIC CHEMISTRY》*
许兴友,等: "《无机及分析化学》", 31 July 2014*

Cited By (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN106905398A (en)*2017-01-252017-06-30浙江农林大学A kind of synthetic method of Suo Feibuwei
CN106905398B (en)*2017-01-252019-12-10浙江农林大学Synthetic method of sofosbuvir
CN107253971A (en)*2017-07-182017-10-17江苏正济药业股份有限公司A kind of Suo Feibuwei preparation method
CN109422790A (en)*2017-08-282019-03-05常州制药厂有限公司A kind of new preparation process of Suo Feibuwei
CN109422790B (en)*2017-08-282022-02-22常州制药厂有限公司Novel preparation process of sofosbuvir
CN109467577A (en)*2018-12-062019-03-15南通常佑药业科技有限公司A kind of preparation method of Suo Feibuwei crystal form and amorphous products
CN113234102A (en)*2021-05-182021-08-10宁波大学Three-coordinate phosphorus derivative and intermediate and preparation method thereof
CN115925754A (en)*2022-10-242023-04-07江苏阿尔法药业股份有限公司Catalytic synthesis process of sofosbuvir
CN115925754B (en)*2022-10-242024-07-30江苏阿尔法药业股份有限公司Sofosbuvir catalytic synthesis process

Also Published As

Publication numberPublication date
CN105669804B (en)2018-08-17

Similar Documents

PublicationPublication DateTitle
CN105669804A (en)Preparation method of sofosbuvir
WO2016112746A1 (en)Method for preparing ribofuranose phosphate derivatives
CN103848876B (en)A kind of nucleoside phosphoramidite prodrug and preparation method thereof and its application
CN104151352B (en)Preparation method of sofosbuvir intermediate
CA2761656C (en)Amorphous silibinin for the treatment of viral hepatitis
CN106146588A (en)A kind of preparation method of Suo Feibuwei
CN105646629A (en)L-nucleoside compounds and application thereof
CN102718829B (en)The preparation method of TUDCANa
CN106916105A (en)A kind of method that purifying can win U.S.
CN104558035B (en)A kind of purification process of tenofovir prodrug
CN106977543A (en)The preparation technology of improved Suo Feibuwei intermediates
CN109422710A (en)A kind of preparation method of Suo Feibuwei fluorine lactone intermediate
CN104672281A (en)Method for preparing high-purity tenofovir dipivoxil fumarate
CN110964057A (en)Method for preparing sofosbuvir intermediate by using microfluid reaction device
CN108440596B (en)Novel preparation process of tenofovir alafenamide hemifumarate
CN104387421B (en)Adefovir ester monohydrate and preparation method thereof
CN104109182B (en)A kind of method preparing gemcitabine hydrochloride
CN102159576B (en)Improved production method for adefovir dipivoxil
CN103772346A (en)Bicyclol prodrug compound, and preparation method, pharmaceutical composition and application thereof
CN109422790B (en)Novel preparation process of sofosbuvir
CN105461773B (en)Preparation method and intermediate of sofosbuvir
CN103524561B (en)A kind of preparation method of tenofovir monoester fumarate
CN105461775B (en)A kind of Suo Feibuwei preparation method
CN105348320B (en)A kind of Suo Feibuwei intermediates and preparation method thereof
CN105481809A (en)Separation and purification method of salvianolic acid B and preparation method of salvianolic acid B magnesium salt

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
GR01Patent grant
GR01Patent grant

[8]ページ先頭

©2009-2025 Movatter.jp